Review of "Thrombosis in Clinical Practice"

por Altman, Raul
Publicado 2005

Acute coronary disease Athero-Inflammation: Therapeutic approach

por Altman, Raul
Publicado 2003

Risk factors in coronary atherosclerosis athero-inflammation: the meeting point

por Altman, Raul
Publicado 2003

Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy

por Altman, Raul
Publicado 2007

New oral anticoagulants: are coagulation units still required?

por Altman, Raul
Publicado 2014

Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective

por Altman, Raul, Vidal, Hector O
Publicado 2011

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs

por Altman, Raul, Gonzalez, Claudio Daniel
Publicado 2014

Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs

por Altman, Raul, Gonzalez, Claudio Daniel
Publicado 2015

Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study

por Altman, Raul, Rivas, Ana J, Gonzalez, Claudio D
Publicado 2012

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

por Altman, Raul, Luciardi, Héctor L, Muntaner, Juan, Herrera, Ramón N
Publicado 2004

Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis

por Altman, Raul, Scazziota, Alejandra Silvia, Herrera, Maria de Lourdes, Gonzalez, Claudio
Publicado 2006

The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?

por Altman, Raul, Scazziota, Alejandra, de Lourdes Herrera, Maria, Gonzalez, Claudio D
Publicado 2010